A key element of all cell and gene therapies (CGTs) is cryopreservation, the controlled freezing of cell samples. In cell therapy manufacturing, cell samples are collected and stored for future use, often for decades, so the proper collection, cryopreservation and retrieval of these samples is essential for safe and effective CGTs. In addition, it’s also … Continued
Brian Malone has been with ThermoGenesis for 17 years and is currently serving in a role as a Designer. For him, the most rewarding part of his job is hearing the stories of patients who have been able to recover from debilitating diseases thanks to the cell therapy technology that he helps create. We asked … Continued
Cell and gene therapies (CGT) are gaining greater popularity in the community as viable regenerative medicine options. Although there has been a lot of progress made in a relatively short amount of time, there are challenges to overcome before these treatments can become more mainstream. As a solution to the concerns with rapid, scalable manufacturing, … Continued
RANCHO CORDOVA, Calif., September 14, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company was awarded a $250,000 Phase I Small Business Innovation Research (SBIR) grant to develop and test the single-use sterile cell processing disposable, … Continued
The Importance of Cryopreservation in GMP Cell Therapy Cryopreservation is a process that preserves cells and tissues by freezing samples to very low temperatures over a period of time. It’s important to the cell therapy manufacturing process because cell samples need to be properly stored in order to maintain their viability and functionality later down … Continued
RANCHO CORDOVA, Calif., September 7, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference. If you are an … Continued
Translating a drug from a concept to a treatment that is scalable and manufacturable can be the biggest challenge for developers of cell and gene therapies (CGT). Particularly in this field, the challenge is even greater because the people who are able to perform the necessary tasks need to be highly skilled cell biologists … Continued
Rosalind Castor has been with the company for many years, and is currently serving in a role as Production Supervisor. For her, it’s a privilege to have been a part of the company’s growth, and to be able to make what she considers to be a small contribution to the larger mission of our company … Continued
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., August 12, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the second quarter ended June 30, 2021 … Continued